tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BMRN Stock Latest News

BioMarin Pharmaceutical: Strong Q4 Performance, Future Growth Prospects, and Ongoing Challenges Justify Hold Rating
RatingsBioMarin Pharmaceutical: Strong Q4 Performance, Future Growth Prospects, and Ongoing Challenges Justify Hold Rating
14m ago
BMRN
BioMarin Pharmaceutical: Buy Rating Affirmed on Strong Growth Prospects and Strategic Developments
PremiumRatings
BioMarin Pharmaceutical: Buy Rating Affirmed on Strong Growth Prospects and Strategic Developments
2h ago
BMRN
BioMarin’s Earnings Call Highlights Strong Growth and Optimism
PremiumCompany Announcements
BioMarin’s Earnings Call Highlights Strong Growth and Optimism
12h ago
BMRN
BioMarin Pharmaceutical: Strong Growth Prospects with Strategic Initiatives Justifying Buy Rating
PremiumRatings
BioMarin Pharmaceutical: Strong Growth Prospects with Strategic Initiatives Justifying Buy Rating
19h ago
BMRN
BioMarin price target raised to $80 from $78 at Scotiabank
PremiumThe Fly
BioMarin price target raised to $80 from $78 at Scotiabank
22h ago
BMRN
BioMarin price target raised to $113 from $109 at UBS
PremiumThe FlyBioMarin price target raised to $113 from $109 at UBS
24h ago
BMRN
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Prospects Warrant Buy Rating
Premium
Ratings
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Prospects Warrant Buy Rating
24h ago
BMRN
BioMarin price target raised to $103 from $99 at BofA
Premium
The Fly
BioMarin price target raised to $103 from $99 at BofA
1d ago
BMRN
Strong Financial Performance and Positive Outlook for BioMarin Pharmaceutical
PremiumRatings
Strong Financial Performance and Positive Outlook for BioMarin Pharmaceutical
1d ago
BMRN
Strong Financial Performance and Strategic Growth Drive Buy Rating for BioMarin Pharmaceutical
PremiumRatings
Strong Financial Performance and Strategic Growth Drive Buy Rating for BioMarin Pharmaceutical
1d ago
BMRN
BioMarin price target raised to $126 from $122 at Piper Sandler
PremiumThe Fly
BioMarin price target raised to $126 from $122 at Piper Sandler
1d ago
BMRN
BioMarin price target raised to $82 from $81 at Citi
PremiumThe Fly
BioMarin price target raised to $82 from $81 at Citi
1d ago
BMRN
BioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
PremiumRatingsBioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
1d ago
BMRN
BioMarin Pharmaceutical’s Strong Financial Performance and Growth Prospects Justify Buy Rating
Premium
Ratings
BioMarin Pharmaceutical’s Strong Financial Performance and Growth Prospects Justify Buy Rating
1d ago
BMRN
BioMarin’s Record Growth and 2025 Outlook
Premium
Company Announcements
BioMarin’s Record Growth and 2025 Outlook
1d ago
BMRN
Closing Bell Movers: Carvana down 8% on earnings, Palantir extends decline
PremiumThe Fly
Closing Bell Movers: Carvana down 8% on earnings, Palantir extends decline
2d ago
BHC
FPI
BioMarin sees FY25 EPS $4.20-$4.40, consensus $4.16
PremiumThe Fly
BioMarin sees FY25 EPS $4.20-$4.40, consensus $4.16
2d ago
BMRN
BioMarin reports Q4 non-GAAP EPS 92c, consensus 74c
PremiumThe Fly
BioMarin reports Q4 non-GAAP EPS 92c, consensus 74c
2d ago
BMRN
BMRN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BMRN Upcoming Earnings Report: What to Expect?
4d ago
BMRN
BioMarin stock undervalued at current levels, says JPMorgan
PremiumThe FlyBioMarin stock undervalued at current levels, says JPMorgan
1M ago
BMRN
BioMarin initiates legal action against Ascendis over patent infringement
Premium
The Fly
BioMarin initiates legal action against Ascendis over patent infringement
1M ago
ASND
BMRN
TD Cowen ‘disappointed’ Pfizer ended Sangamo collaboration
Premium
The Fly
TD Cowen ‘disappointed’ Pfizer ended Sangamo collaboration
2M ago
PFE
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >